CLINICAL_TRIALS
trial_result
· 2019-04-11
Clinical Trial Update: the Treatment of Human Bone Marrow Mesenchymal Stem Cells in Ocular Corneal Burn [Phase 2]
Summary
Phase 2 trial evaluating human bone marrow mesenchymal stem cells for ocular corneal burns has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Yat-sen University | Conditions: Chemical Burns | Phase 2 | Status: COMPLETED